The molecular biology and therapeutic potential of Nrf2 in leukemia

Area of Science:

• Molecular Biology
• Oncology
• Cellular Biology

Background:

• NF-E2-related factor 2 (Nrf2) is a transcription factor with complex roles in cancer, acting as both a tumor suppressor and proto-oncogene.
• The Nrf2 pathway regulates critical cellular processes including metabolism, autophagy, inflammation, and redox homeostasis, impacting cell survival.
• Nrf2 activation can promote cancer progression by enhancing proliferation, angiogenesis, metastasis, and resistance to therapy.

Purpose of the Study:

• To elucidate the multifaceted role of Nrf2 in various cancer types.
• To investigate the therapeutic potential of targeting Nrf2 in combination with chemotherapy, particularly for leukemia.
• To examine the interplay between Nrf2 and NF-κB in redox regulation, inflammation, and leukemia.

Main Methods:

• Literature review and summary of existing studies on Nrf2 in cancer.
• Analysis of Nrf2's role in chemoresistance and radioresistance in solid tumors and hematological malignancies.
• Discussion of the synergistic and antagonistic interactions between Nrf2 and NF-κB.

Main Results:

• Nrf2 plays a critical role in protecting cancer cells, especially leukemic cells, from chemotherapeutic agents.
• Targeting Nrf2 presents a potential strategy to enhance the efficacy of chemotherapy in leukemia treatment.
• Nrf2 and NF-κB exhibit complex interactions, influencing redox pathways, inflammation, and leukemia progression.

Conclusions:

• Nrf2 is a key regulator of cancer cell survival and therapeutic resistance.
• Combined targeting of Nrf2 and chemotherapy warrants further investigation as a promising approach for leukemia treatment.
• Understanding the Nrf2-NF-κB axis is crucial for developing novel cancer therapies.